Kinin modulation of conventional outflow facility in the bovine eye

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 5, 2006, Pages 310-316

  Webb, Jerry G ^a   Husain, Shahid ^a   Yates, Phillip W ^a   Crosson, Craig E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; GELATINASE B; ICATIBANT; ILOMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; ARTICLE; CONTROLLED STUDY; COW; ENZYME RELEASE; EXTRACELLULAR FLUID; EYE BLOOD FLOW; FLOW MEASUREMENT; FLUID FLOW; INTRAOCULAR PRESSURE; KALLIKREIN KININ SYSTEM; LACRIMAL FLUID; NONHUMAN; TRABECULAR MESHWORK; WESTERN BLOTTING;

ANIMALS; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR; BRADYKININ; CATTLE; CELLS, CULTURED; DIPEPTIDES; EYE; MATRIX METALLOPROTEINASE 9; PROTEASE INHIBITORS; RECEPTOR, BRADYKININ B2; TIME FACTORS;

EID: 33750721728     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.310     Document Type: Article

References (28)

1. Bhoola, K.D., Figueroa, C.D., and Worthy, K. Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol. Rev. 44:1-80, 1992.
2. Ma, J.-X., Song, Q., Hatcher, H.C., et al. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Exp. Eye Res. 63:19-26, 1996.
3. Igic, R. Kallikrein and kininases in ocular tissues. Exp. Eye Res. 41:117-120, 1985.
4. Laliberte, M.F., Laliberte, F., Alhenc-Gelas, F., et al. Immunohistochemistry of angiotensin I-converting enzyme in rat eye structures involved in aqueous humor regulation. Lab. Invest. 59:263-270, 1988.
5. Sharif, N.A., and Xu, S.X. Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-immortalized human trabecular meshwork cells. Exp. Eye Res. 63:631-637, 1996.
6. Llobet, A., Gual, A., Pales, J., et al. Bradykinin decreases outflow facility in perfused anterior segments and induces shape changes in passaged BTM cells in vitro. Invest. Ophthalmol. Vis. Sci. 40:113-125, 1999.
7. 2 signaling in bovine trabecular meshwork cells. Exp. Eye Res. 76:283-289, 2003.
8. Polansky, J.R., Kurtz, R.M., Alvarado, J.A., et al. Eicosanoid production and glucocorticoid regulatory mechanisms in cultured human trabecular meshwork cells. Prog. Clin. Biol. Res. 312:113-138, 1989.
9. Erickson-Lamy, K., Rohen, J.W., and Grant, W.M. Outflow facility studies in the perfused bovine aqueous outflow pathways. Curr. Eye Res. 7:799-807, 1988.
10. 1 receptor modulation of MMP-2 secretion by trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 43:3016-3020, 2002.
11. Alexander, J.P., Samples, J.R., and Acott, T.S. Growth factor and cytokine modulation of trabecular mesh-work matrix metalloproteinase and TIMP expression. Curr. Eye. Res. 17:276-285, 1998.
12. Zhou, L., Li, Y., and Yue, B.Y. Glucocorticoid effects on extracellular matrix proteins and integrins in bovine trabecular meshwork cells in relation to glaucoma. Int. J. Mol. Med. 1:339-346, 1998.
13. Bradley, J.M., Vranka, J., Colvis, C.M., et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest. Ophthalmol. Vis. Sci. 39:2649-2658, 1998.
14. Bradley, J.M., Kelley, M.J., Zhu, X., et al. Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest. Ophthalmol. Vis. Sci. 42:1505-1513, 2001.
15. Sternlicht, M.D., and Werb, Z. How matrix metalloproteinases regulate cell behavior. Ann. Rev. Cell Dev. Biol. 17:463-516, 2001.
16. Borregaard, N., and Cowland, J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503-3521, 1997.
17. Lindsey, M., Wedin, K., Brown, M.D., et al. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 103:2181-2187, 2001.
18. 6- cyclohexyladenosine. Invest. Ophthalmol. Vis. Sci. 46:3795-3799, 2005.
19. Hao, J.L., Nagano, T., Nakamura, M., et al. Effect of galardin on collagen degradation by Pseudomonas aeruginosa. Exp. Eye Res. 69:595-601, 1999.
20. Agren, M.S., Mirastschijski, U., Karlsmark, T., et al. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp. Dermatol. 10:337-348, 2001.
21. Sabanay, I., Gabelt, B.T., Tian, B., et al. H-7 effects on the structure and fluid conductance of monkey trabecular meshwork. Arch. Ophthalmol. 118:955-962, 2000.
22. Rao, P.V., Deng, P.-F., Kumar, J., et al. Modulation of aqueous humor outflow facility by the rho kinase-specific inhibitor Y-27632. Invest. Ophthalmol. Vis. Sci. 42:1029-1037, 2001.
23. Overby, D., Gong, H., Qiu, G., et al. The mechanism of increasing outflow facility during washout in the bovine eye. Invest. Ophthalmol Vis. Sci. 43:3455-3464, 2002.
24. Utoguchi, N., Mizuguchi, H., Dantakean, A., et al. Effect of tumor cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen. Br. J. Cancer. 73:24-28, 1996.
25. Alexander, J.S., and Elrod, J.W. Extracellular matrix, junctional integrity, and matrix metalloproteinase interactions in endothelial permeability regulation. J. Anat. 200:561-574, 2002.
26. Ehringer, W.D., Wang, O.-L., Haq, A., et al. Bradykinin and a-thrombin increase human umbilical vein endothelial macromolecular permeability by different mechanisms. Inflammation 24:175-193, 2000.
27. Toris, C.B., Camras, C.B., Yablonski, M.E., et al. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv. Ophthalmol. 41:S69-S75, 1997.
28. Dijkstra, B.G., Schneemann, A., and Hoyng, P.F. Flow after prostaglandin E1 is mediated by receptor-coupled adenylyl cyclase in human anterior segments. Invest. Ophthalmol. Vis. Sci. 40:2622-2626, 1999.